Skip to main content

Advertisement

SpringerLink
Log in

Smoking and aggressive prostate cancer: a review of the epidemiologic evidence

  • Review article
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Although tobacco use has been recognized as one of the leading causes of cancer morbidity and mortality, a role of smoking in the occurrence of prostate cancer has not been established. However, evidence indicates that factors that influence the incidence of prostate cancer may differ from those that influence progression and fatality from the disease. Thus, we reviewed and summarized results from prospective cohort studies that assessed the relation between smoking and fatal prostate cancer risk, as well as epidemiological and clinical studies that focused on aggressive behavior in prostate cancer, such as poorer survival, advanced stage, or poorer differentiation at diagnosis. The majority of the prospective cohort studies showed that current smoking is associated with a moderate increase of ~30% in fatal prostate cancer risk compared to never/non-smokers. This association is likely to be an underestimate of the effect of smoking because most studies had a single assessment of smoking at baseline and long follow-up times, and the association was considerably stronger in some sub-groups of heaviest smokers, or when smoking was assessed in a relatively short period (within 10 years) prior to cancer mortality. Using aggressive behavior of prostate cancer as outcome, current smoking was associated with significantly elevated risk, ranging from around twofold to threefold or higher. Although alternative explanations, such as publication bias, residual confounding, screening bias, and the influence of smoking-related comorbidities cannot be ruled out entirely, these findings suggest that smoking is associated with aggressive behavior of prostate cancers or with a sub-group of rapidly progressing prostate cancer. Based on evidence presented in this review, cigarette smoking is likely to be a risk factor for prostate cancer progression and should be considered as a relevant exposure in prostate cancer research and prevention of mortality from this cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Ward E et al (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71–96

    Article  PubMed  Google Scholar 

  2. Assikis V, Brawley OW (2004) Chemoprevention in prostate cancer. Curr Probl Cancer 28:218–230

    Article  PubMed  Google Scholar 

  3. Andriole GL, Crawford ED, Grubb RLIII et al (2009) Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360:1310–1319

    Article  CAS  PubMed  Google Scholar 

  4. Schroder FH, Hugosson J, Roobol MJ et al (2009) Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360:1320–1328

    Article  PubMed  Google Scholar 

  5. Hickey K, Do KA, Green A (2001) Smoking and prostate cancer. Epidemiol Rev 23:115–125

    CAS  PubMed  Google Scholar 

  6. Levi F, La Vecchia C (2001) Tobacco smoking and prostate cancer: time for an appraisal. Ann Oncol 12:733–738

    Article  CAS  PubMed  Google Scholar 

  7. Giovannucci E, Liu Y, Platz EA, Stampfer MJ, Willett WC (2007) Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer 121:1571–1578

    Article  CAS  PubMed  Google Scholar 

  8. Carstensen JM, Pershagen G, Eklund G (1987) Mortality in relation to cigarette and pipe smoking: 16 years’ observation of 25, 000 Swedish men. J Epidemiol Community Health 41:166–172

    Article  CAS  PubMed  Google Scholar 

  9. Akiba S, Hirayama T (1990) Cigarette smoking and cancer mortality risk in Japanese men and women–results from reanalysis of the six-prefecture cohort study data. Environ Health Perspect 87:19–26

    Article  CAS  PubMed  Google Scholar 

  10. Hsing AW, McLaughlin JK, Schuman LM et al (1990) Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study. Cancer Res 50:6836–6840

    CAS  PubMed  Google Scholar 

  11. Hsing AW, McLaughlin JK, Hrubec Z, Blot WJ, Fraumeni JF Jr (1991) Tobacco use and prostate cancer: 26-year follow-up of US veterans. Am J Epidemiol 133:437–441

    CAS  PubMed  Google Scholar 

  12. Tverdal A, Thelle D, Stensvold I, Leren P, Bjartveit K (1993) Mortality in relation to smoking history: 13 years’ follow-up of 68, 000 Norwegian men and women 35–49 years. J Clin Epidemiol 46:475–487

    Article  CAS  PubMed  Google Scholar 

  13. Doll R, Peto R, Wheatley K, Gray R, Sutherland I (1994) Mortality in relation to smoking: 40 years’ observations on male British doctors. BMJ 309:901–911

    CAS  PubMed  Google Scholar 

  14. Adami HO, Bergstrom R, Engholm G et al (1996) A prospective study of smoking and risk of prostate cancer. Int J Cancer 67:764–768

    Article  CAS  PubMed  Google Scholar 

  15. Coughlin SS, Neaton JD, Sengupta A (1996) Cigarette smoking as a predictor of death from prostate cancer in 348, 874 men screened for the multiple risk factor intervention trial. Am J Epidemiol 143:1002–1006

    CAS  PubMed  Google Scholar 

  16. Rodriguez C, Tatham LM, Thun MJ, Calle EE, Heath CW Jr (1997) Smoking and fatal prostate cancer in a large cohort of adult men. Am J Epidemiol 145:466–475

    CAS  PubMed  Google Scholar 

  17. Giovannucci E, Rimm EB, Ascherio A et al (1999) Smoking and risk of total and fatal prostate cancer in United States health professionals. Cancer Epidemiol Biomark Prev 8:277–282

    CAS  Google Scholar 

  18. Lotufo PA, Lee IM, Ajani UA, Hennekens CH, Manson JE (2000) Cigarette smoking and risk of prostate cancer in the physicians’ health study (United States). Int J Cancer 87:141–144

    Article  CAS  PubMed  Google Scholar 

  19. Rohrmann S, Genkinger JM, Burke A et al (2007) Smoking and risk of fatal prostate cancer in a prospective U.S. study. Urology 69:721–725

    Article  PubMed  Google Scholar 

  20. Batty GD, Kivimaki M, Gray L, Smith GD, Marmot MG, Shipley MJ (2008) Cigarette smoking and site-specific cancer mortality: testing uncertain associations using extended follow-up of the original Whitehall study. Ann Oncol 19:996–1002

    Article  CAS  PubMed  Google Scholar 

  21. Daniell HW (1995) A worse prognosis for smokers with prostate cancer. J Urol 154:153–157

    Article  CAS  PubMed  Google Scholar 

  22. Yu GP, Ostroff JS, Zhang ZF, Tang J, Schantz SP (1997) Smoking history and cancer patient survival: a hospital cancer registry study. Cancer Detect Prev 21:497–509

    CAS  PubMed  Google Scholar 

  23. Oefelein MG, Resnick MI (2004) Association of tobacco use with hormone refractory disease and survival of patients with prostate cancer. J Urol 171:2281–2284

    Article  PubMed  Google Scholar 

  24. Pickles T, Liu M, Berthelet E, Kim-Sing C, Kwan W, Tyldesley S (2004) The effect of smoking on outcome following external radiation for localized prostate cancer. J Urol 171:1543–1546

    Article  CAS  PubMed  Google Scholar 

  25. Pantarotto J, Malone S, Dahrouge S, Gallant V, Eapen L (2007) Smoking is associated with worse outcomes in patients with prostate cancer treated by radical radiotherapy. BJU Int 99:564–569

    Article  PubMed  Google Scholar 

  26. Gong Z, Agalliu I, Lin DW, Stanford JL, Kristal AR (2008) Cigarette smoking and prostate cancer-specific mortality following diagnosis in middle-aged men. Cancer Causes Control 19:25–31

    Article  PubMed  Google Scholar 

  27. Doll R, Peto R, Boreham J, Sutherland I (2005) Mortality from cancer in relation to smoking: 50 years observations on British doctors. Br J Cancer 92:426–429

    Article  CAS  PubMed  Google Scholar 

  28. Hussain F, Aziz H, Macchia R, Avitable M, Rotman M (1992) High grade adenocarcinoma of prostate in smokers of ethnic minority groups and Caribbean Island immigrants. Int J Radiat Oncol Biol Phys 24:451–461

    CAS  PubMed  Google Scholar 

  29. Cerhan JR, Torner JC, Lynch CF et al (1997) Association of smoking, body mass, and physical activity with risk of prostate cancer in the Iowa 65+ Rural Health Study (United States). Cancer Causes Control 8:229–238

    Article  CAS  PubMed  Google Scholar 

  30. Spitz MR, Strom SS, Yamamura Y et al (2000) Epidemiologic determinants of clinically relevant prostate cancer. Int J Cancer 89:259–264

    Article  CAS  PubMed  Google Scholar 

  31. Kobrinsky NL, Klug MG, Hokanson PJ, Sjolander DE, Burd L (2003) Impact of smoking on cancer stage at diagnosis. J Clin Oncol 21:907–913

    Article  PubMed  Google Scholar 

  32. Plaskon LA, Penson DF, Vaughan TL, Stanford JL (2003) Cigarette smoking and risk of prostate cancer in middle-aged men. Cancer Epidemiol Biomark Prev 12:604–609

    CAS  Google Scholar 

  33. Roberts WW, Platz EA, Walsh PC (2003) Association of cigarette smoking with extraprostatic prostate cancer in young men. J Urol 169:512–516

    Article  PubMed  Google Scholar 

  34. Merrick GS, Butler WM, Wallner KE, Galbreath RW, Lief JH, Adamovich E (2004) Effect of cigarette smoking on biochemical outcome after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 58:1056–1062

    CAS  PubMed  Google Scholar 

  35. Zmuda JM, Cauley JA, Kriska A, Glynn NW, Gutai JP, Kuller LH (1997) Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former multiple risk factor intervention trial participants. Am J Epidemiol 146:609–617

    CAS  PubMed  Google Scholar 

  36. Dai WS, Gutai JP, Kuller LH, Cauley JA (1988) Cigarette smoking and serum sex hormones in men. Am J Epidemiol 128:796–805

    CAS  PubMed  Google Scholar 

  37. Waalkes MP, Rehm S (1994) Cadmium and prostate cancer. J Toxicol Environ Health 43:251–269

    Article  CAS  PubMed  Google Scholar 

  38. Pour PM (1983) Prostatic cancer induced in MRC rats by N-nitrosobis(2-oxopropyl)-amine and N-nitrosobis(2-hydroxypropyl)amine. Carcinogenesis 4:49–55

    Article  CAS  PubMed  Google Scholar 

  39. Heeschen C, Jang JJ, Weis M et al (2001) Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 7:833–839

    Article  CAS  PubMed  Google Scholar 

  40. Jain RK (2001) Clearing the smoke on nicotine and angiogenesis. Nat Med 7:775–777

    Article  CAS  PubMed  Google Scholar 

  41. Villablanca AC (1998) Nicotine stimulates DNA synthesis and proliferation in vascular endothelial cells in vitro. J Appl Physiol 84:2089–2098

    CAS  PubMed  Google Scholar 

  42. Hahn RG (2001) Smoking increases the risk of large scale fluid absorption during transurethral prostatic resection. J Urol 166:162–165

    Article  CAS  PubMed  Google Scholar 

  43. Enokida H, Shiina H, Urakami S et al (2006) Smoking influences aberrant CpG hypermethylation of multiple genes in human prostate carcinoma. Cancer 106:79–86

    Article  CAS  PubMed  Google Scholar 

  44. Yang J, Qian LX, Wu HF et al (2006) Genetic polymorphisms in the cytochrome P450 1A1 and 2E1 genes, smoking, drinking and prostate cancer susceptibility: a case–control study in a Han nationality population in Southern China. Int J Urol 13:773–780

    Article  CAS  PubMed  Google Scholar 

  45. Mao GE, Morris G, Lu QY et al (2004) Glutathione S-transferase P1 Ile105Val polymorphism, cigarette smoking and prostate cancer. Cancer Detect Prev 28:368–374

    Article  CAS  PubMed  Google Scholar 

  46. Quinones LA, Irarrazabal CE, Rojas CR et al (2006) Joint effect among p53, CYP1A1, GSTM1 polymorphism combinations and smoking on prostate cancer risk: an exploratory genotype-environment interaction study. Asian J Androl 8:349–355

    Article  CAS  PubMed  Google Scholar 

  47. Hamasaki T, Inatomi H, Katoh T et al (2003) N-acetyltransferase-2 gene polymorphism as a possible biomarker for prostate cancer in Japanese men. Int J Urol 10:167–173

    Article  CAS  PubMed  Google Scholar 

  48. Wadelius M, Autrup JL, Stubbins MJ et al (1999) Polymorphisms in NAT2, CYP2D6, CYP2C19 and GSTP1 and their association with prostate cancer. Pharmacogenetics 9:333–340

    Article  CAS  PubMed  Google Scholar 

  49. Nock NL, Liu X, Cicek MS et al (2006) Polymorphisms in polycyclic aromatic hydrocarbon metabolism and conjugation genes, interactions with smoking and prostate cancer risk. Cancer Epidemiol Biomark Prev 15:756–761

    Article  CAS  Google Scholar 

  50. Kelada SN, Kardia SL, Walker AH, Wein AJ, Malkowicz SB, Rebbeck TR (2000) The glutathione S-transferase-mu and -theta genotypes in the etiology of prostate cancer: genotype-environment interactions with smoking. Cancer Epidemiol Biomark Prev 9:1329–1334

    CAS  Google Scholar 

  51. Agundez JA (2004) Cytochrome P450 gene polymorphism and cancer. Curr Drug Metab 5:211–224

    Article  CAS  PubMed  Google Scholar 

  52. Anonymous (1994) The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 330:1029–1035

  53. Heinonen OP, Albanes D, Virtamo J et al (1998) Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 90:440–446

    Article  CAS  PubMed  Google Scholar 

  54. Kirsh VA, Hayes RB, Mayne ST et al (2006) Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk. J Natl Cancer Inst 98:245–254

    Article  CAS  PubMed  Google Scholar 

  55. Johnson AR, Munoz A, Gottlieb JL, Jarrard DF (2007) High dose zinc increases hospital admissions due to genitourinary complications. J Urol 177:639–643

    Article  CAS  PubMed  Google Scholar 

  56. Chan JM, Stampfer MJ, Ma J, Rimm EB, Willett WC, Giovannucci EL (1999) Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States. Cancer Epidemiol Biomark Prev 8:893–899

    CAS  Google Scholar 

  57. Lippman SM, Klein EA, Goodman PJ et al (2009) Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the selenium and vitamin E cancer prevention trial (SELECT). JAMA 301:39–51

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This project was funded by E.G.’s Research and Teaching Funds from the Department of Nutrition at the Harvard School of Public Health.

Author information

Authors and Affiliations

  1. Department of Nutrition, Harvard School of Public Health, 665 Huntington Avenue, Boston, MA, 02115, USA

    Ke Zu & Edward Giovannucci

  2. Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA

    Edward Giovannucci

  3. Channing Laboratory, Department of Medicine, Harvard Medical School and Brigham and Women’s Hospital, Boston, MA, USA

    Edward Giovannucci

Authors
  1. Ke Zu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Edward Giovannucci
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Edward Giovannucci.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zu, K., Giovannucci, E. Smoking and aggressive prostate cancer: a review of the epidemiologic evidence. Cancer Causes Control 20, 1799–1810 (2009). https://doi.org/10.1007/s10552-009-9387-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-009-9387-y

Keywords

Search

Navigation